RAG
NVNO

RIA Advisory Group’s enVVeno Medical NVNO Stock Holding History

RIA Advisory Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$238K Buy
+1,248
New +$224K 0.1% 123

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RIA Advisory Group's NVNO Position: Q1 2024 in Review

RIA Advisory Group opened a new position in enVVeno Medical (NVNO) in Q1 2024: 1,248 shares worth $238K. The stake represents 0.1% of the portfolio and ranks #123 among its holdings.

31 funds tracked by Wall St. Rank hold NVNO as of Q1 2024.

  • RIA Advisory Group held 1,248 shares of enVVeno Medical worth $238K as of Q1 2024.
  • enVVeno Medical was a new RIA Advisory Group position in Q1 2024.
  • enVVeno Medical made up 0.1% of RIA Advisory Group's portfolio in Q1 2024, its #123 holding.
  • 31 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2024.

Based on RIA Advisory Group's 13F filing for Q1 2024, filed 3 May 2024.